3.0700
0.0000
(0.00%)
At close: January 24 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,620.0000
-12,873.0000
-18,988.0000
-23,795.0000
-9,743.0000
Investing Cash Flow
1,138.0000
370.0000
-17.0000
12,160.0000
-12,713.0000
Financing Cash Flow
5,918.0000
7,027.0000
6,134.0000
29,715.0000
21,953.0000
End Cash Position
2,175.0000
5,568.0000
11,053.0000
23,926.0000
5,847.0000
Capital Expenditure
-139.0000
-220.0000
-141.0000
-344.0000
-214.0000
Issuance of Capital Stock
3,238.0000
5,541.0000
--
16,584.0000
23,486.0000
Issuance of Debt
4,000.0000
1,890.0000
9,510.0000
20,484.0000
8,730.0000
Repayment of Debt
-1,492.0000
-1,545.0000
-2,088.0000
-3,604.0000
-4,077.0000
Free Cash Flow
-10,759.0000
-13,093.0000
-19,129.0000
-24,139.0000
-9,957.0000
12/31/2020 - 2/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MAAT.PA MaaT Pharma SA
8.02
-1.47%
ALSEN.PA Sensorion SA
0.6220
-1.27%
SIGHT.PA GenSight Biologics S.A.
0.2845
+3.64%
USRM U.S. Stem Cell, Inc.
0.0001
0.00%
ALCLS.PA Cellectis S.A.
1.5640
+1.56%
OSE.PA OSE Immunotherapeutics SA
6.37
-0.62%
ENSCW Leisure Acquisition Corp.
0.0297
+41.43%
DBV.PA DBV Technologies S.A.
0.8750
+1.27%
RGBP Regen BioPharma, Inc.
0.0762
0.00%
RLYB Rallybio Corporation
0.8800
-3.87%